These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 16357308)
1. Destabilization and early termination of spiral-wave reentry by a class III antiarrhythmic agent, nifekalant, in a perfused two-dimensional layer of rabbit ventricular myocardium. Circ Res; 2006 Feb; 98(3):e28. PubMed ID: 16357308 [No Abstract] [Full Text] [Related]
2. Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant. Yamazaki M; Honjo H; Nakagawa H; Ishiguro YS; Okuno Y; Amino M; Sakuma I; Kamiya K; Kodama I Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H539-48. PubMed ID: 16936005 [TBL] [Abstract][Full Text] [Related]
3. Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium. Kodama I; Honjo H; Yamazaki M; Nakagawa H; Ishiguro Y; Okuno Y; Sakuma I; Kamiya K J Electrocardiol; 2005 Oct; 38(4 Suppl):126-30. PubMed ID: 16226087 [TBL] [Abstract][Full Text] [Related]
4. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter. Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127 [TBL] [Abstract][Full Text] [Related]
9. [Treatment for perioperative arrhythmias with nifekalant hydrochloride]. Nishida M; Okada H; Murakami M; Hamano K Kyobu Geka; 2006 Mar; 59(3):210-3. PubMed ID: 16528993 [TBL] [Abstract][Full Text] [Related]
10. Intracellular calcium and vulnerability to fibrillation and defibrillation in Langendorff-perfused rabbit ventricles. Hwang GS; Hayashi H; Tang L; Ogawa M; Hernandez H; Tan AY; Li H; Karagueuzian HS; Weiss JN; Lin SF; Chen PS Circulation; 2006 Dec; 114(24):2595-603. PubMed ID: 17116770 [TBL] [Abstract][Full Text] [Related]
11. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm. Fuchs T; Groysman R; Meilichov I Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469 [TBL] [Abstract][Full Text] [Related]
12. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride. Ohashi J; Yasuda S; Miyazaki S; Shimizu W; Morii I; Kurita T; Kawamura A; Kamakura S; Nonogi H J Cardiovasc Pharmacol; 2006 Dec; 48(6):274-9. PubMed ID: 17204905 [TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation. Tan HL; Smits JP; Loef A; Tanck MW; Hardziyenka M; Campian ME Europace; 2008 Jan; 10(1):99-104. PubMed ID: 18094018 [TBL] [Abstract][Full Text] [Related]
15. Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model. Tabereaux PB; Walcott GP; Rogers JM; Kim J; Dosdall DJ; Robertson PG; Killingsworth CR; Smith WM; Ideker RE Circulation; 2007 Sep; 116(10):1113-9. PubMed ID: 17698730 [TBL] [Abstract][Full Text] [Related]
16. Effects of wall stress on the dynamics of ventricular fibrillation: a simulation study using a dynamic mechanoelectric model of ventricular tissue. Hirabayashi S; Inagaki M; Hisada T J Cardiovasc Electrophysiol; 2008 Jul; 19(7):730-9. PubMed ID: 18284504 [TBL] [Abstract][Full Text] [Related]
17. CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels. Dai DZ Cardiovasc Drug Rev; 2006; 24(2):101-15. PubMed ID: 16961724 [TBL] [Abstract][Full Text] [Related]
18. Alternans amplification following a two-stimulus protocol in a one-dimensional cardiac ionic model of reentry: from annihilation to double-wave quasiperiodic reentry. Comtois P; Vinet A Chaos; 2007 Jun; 17(2):023125. PubMed ID: 17614679 [TBL] [Abstract][Full Text] [Related]